{
    "nctId": "NCT00686127",
    "briefTitle": "Symptom Management After Breast Cancer Surgery",
    "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled Trial (RDBPCT) of the Effectiveness of the Lidocaine Patch in the Management of Neuropathic Pain After Breast Cancer Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Neuropathic Pain, Postmastectomy Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 21,
    "primaryOutcomeMeasure": "Change in Pain Intensity on an 11-point Scale From Baseline to 12 Weeks",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult women \\>18 years who develop neuropathic pain in the breast scar area and/or ipsilateral arm following breast cancer surgery\n* Has a healed incision(s)\n* Has no recurrent disease in the painful area\n* Is able to read, write and understand English\n\nExclusion Criteria:\n\n* Presence of another type of pain that is more severe than the neuropathic pain\n* Use of an opioid analgesic of greater than 60 mg codeine/day\n* Is actively trying to become pregnant\n* Has a medical contraindication to the use of lidocaine\n* Has an allergy to lidocaine\n* Is taking a coanalgesic for neuropathic pain.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}